VitaDX

VitaDX

Private
RennesHealthcare & Life Scienceshttps://vitadx.com/

Last Round

VC Round

Jun 20, 2025

Total Funding Raised

$3.12M

Company Overview

VitaDX is a med-tech company that develops and commercializes cancer diagnostic solutions combining image analysis and artificial intelligence with its patented VisioCyt® technology.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Medical AI, Medical Imaging, Computer Vision

Business Model

B2B

Customer Profile

Usage-Based SaaS, Services & Consulting

AI Layer

Application

Keywords

cancer diagnosticsAI diagnosticsbladder cancer testdigital pathologynon-invasive diagnosticsmedical image analysisin vitro diagnosticIVDcomputational pathologymedical AIcytologypathology softwareCE IVDR markcomputer visionthyroid cancer diagnosis

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

VitaDX Comps

Public and private peers based on sector, stage, and business model.

CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

VitaDX Funding Rounds

Historical fundraising activity

RoundDateAmount RaisedValuationInvestorsSources
VC RoundJun 20, 2025
VC RoundSep 4, 2020
VC RoundJun 24, 2019
SeedJun 7, 2017
AngelJul 1, 2015
Grant
Apr 28, 2015

VitaDX Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Feb 19, 2026

    Grew 24% QoQ from 21 to 26 employees.

  • Jan 25, 2026

    Monthly visitors grew 464% MoM, reaching 1K.

VitaDX Filings

SEC and related filings with document metadata.

TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

VitaDX Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about VitaDX's valuation, stock price, and market status.

Firmographic Details

HeadquartersRennes
Employee Range26
Year Founded2015
Last FundingJun 20, 2025

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.







Disclaimer All investments involve risk, including the risk of loss of principal. You should carefully consider your investment objectives, risks, transaction costs and other expenses before deciding to invest in options, swaps or other investments.This does not constitute an offer by Caplight Technologies, Inc. to sell, or a solicitation of an offer to buy, any securities and may not be used or relied upon in connection with any offer or sale of securities. An offer or solicitation can be made only through the delivery of final offering document(s) and purchase agreement(s), and will be subject to the terms and conditions and risks delivered in such documents. Any securities offered are offered through Caplight Markets LLC, member FINRA/SIPC.